Q2 2028
Ends Apr 30, 2028
Revenue
$1.0B
$1.0B to $1.0B
EPS
0.38
0.37 to 0.39
No analyst count
EPS: No analyst count
Apr 29, 03:13 AM UTC
stable/analyst-estimates
Healthcare
Live Price
Offline$14.22
-3.72% today
Window Change
-20.12%
Window
Mar 6, 2026 → Jun 18, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 73 bars · Mar 6, 2026 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
MiniMed Group, Inc. Common Stock (MMED) is a fund with a market cap of $3.40B and listed on NASDAQ. The fund last traded around $14.22 and down 20.1% across the available one-year price window (Mar 6, 2026 → Jun 18, 2026). Valuation is more restrained than many high-expectation growth names at price/sales 2.2. Stock Foundry combines MMED price history, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
MMED
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
MMED Max Drawdown
-41.59%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for MMED and SPY.
EPS Consensus
0.38
Range 0.37 → 0.39
No analyst count
vs prior: +30.1%Revenue Outlook
$1.0B
Range $1.0B → $1.0B
No analyst count
vs prior: +5.0%Consensus Spread
Lower spread suggests tighter agreement across covering analysts.
Trend
Consensus average across visible periods
Trend
Average analyst revenue estimate
Timeline
Sorted by period end date. Includes both cached rows and live fallbacks from FMP.
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.